Cipher Pharmaceuticals Inc. has acquired Charleston, SC-based Innocutis Holdings LLC, a privately held specialty dermatology company, for $45.5 million. The acquisition marks Canada-based Cipher’s commercial entry to the U.S. market. “Innocutis provides us with commercial infrastructure, revenue-generating branded prescription products, and a talented team, including a 31-person sales force that shares our customer-focused philosophy,” said Shawn O’Brien, president and chief executiv...